Skip to main content
. 2022 May 26;6(2):e124–e134. doi: 10.1055/s-0042-1748756

Fig. 4.

Fig. 4

Bleeding rates before immune tolerance induction (ITI) and after achievement of criteria I, II, and III. FVIII, factor VIII.